These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1811295)

  • 1. Subarachnoid fibrinolytic treatment for the prevention of cerebral vasospasm.
    Findlay JM
    Semin Neurol; 1991 Dec; 11(4):400-10. PubMed ID: 1811295
    [No Abstract]   [Full Text] [Related]  

  • 2. [An experimental study on intrathecal injection of fibrinolytic agent for angiospasm following subarachnoid hemorrhage in the dogs (author's transl)].
    Yoshida Y; Handa H; Hayashi T; Amo M; Aoki M; Kusuno K; Lee E; Uno T
    Nihon Geka Hokan; 1979 Mar; 48(2):188-96. PubMed ID: 162263
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy with tissue plasminogen activator for prevention of vasospasm in experimental subarachnoid hemorrhage: its efficacy and problems.
    Asada M; Kong J; Nakamura M; Tamaki N
    Neurol Res; 1996 Aug; 18(4):342-4. PubMed ID: 8875453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prevention and treatment of vasospasm in subarachnoid hemorrhage].
    Tomasello F; D'Avella D
    Minerva Anestesiol; 1998 May; 64(5):217-20. PubMed ID: 9773662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of timing of intrathecal fibrinolytic therapy on cerebral vasospasm in a primate model of subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kanamaru K; Grace M; Baughman R
    Neurosurgery; 1990 Feb; 26(2):201-6. PubMed ID: 2106630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular response to greater petrosal nerve section as method of prevention of experimental cerebral vasospasm in subarachnoid hemorrhage.
    Ryba M; Kukwa A; Janczewski W
    Neuropatol Pol; 1985; 23(2):247-53. PubMed ID: 4047406
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
    Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
    Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of cerebral vasospasm by thrombolytic therapy using t-PA].
    Miyamoto S; Kikuchi H; Nagata I
    Nihon Rinsho; 1993 Dec; 51 Suppl():404-6. PubMed ID: 8121020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Preventive effect of intracisternal methylprednisolone on symptomatic vasospasm after aneurysmal subarachnoid hemorrhage].
    Ohkuma H; Suzuki S; Ogane K; Fujita S; Shibata S; Ito K; Kimura M
    No Shinkei Geka; 1996 Feb; 24(2):135-42. PubMed ID: 8849473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral balloon angioplasty for treatment of vasospasm after subarachnoid hemorrhage.
    Grimes CM
    Heart Lung; 1991 Sep; 20(5 Pt 1):431-5. PubMed ID: 1832667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of experimental arterial spasm caused by subarachnoid hemorrhage by use of an antifibrinolytic agent].
    Fortuna A; La Torre E
    Riv Neurol; 1970; 40(6):424-36. PubMed ID: 5519838
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prophylactic treatment of vasospasm with nimodipine in subarachnoid hemorrhage].
    Procházka M; Gazdíková K; Cigánek L; Koprdová I
    Cas Lek Cesk; 1990 Feb; 129(8):237-9. PubMed ID: 2331740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiorespiratory problems in the use of calcium antagonists for vasospasm prophylaxis in subarachnoid hemorrhage].
    Guggenberger H; Kottler B; Heuser D
    Anaesthesist; 1986 Jul; 35(7):429-32. PubMed ID: 3752488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
    Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
    No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management using nimodipine of cerebral vasospasm secondary to subarachnoid hemorrhage caused by rupture of an intracranial aneurysm].
    Maldonado JA; Milchorena G; López-Camacho O; Madrazo I
    Arch Invest Med (Mex); 1990; 21(2):179-87. PubMed ID: 2103708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effect of nitroglycerin (GTN) on prevention of cerebral vasospasm].
    Sasanuma J; Goto T; Ogayama H; Sasaki J; Watanabe K
    No Shinkei Geka; 1991 Mar; 19(3):227-32. PubMed ID: 1903850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of prazosin hydrochloride on cerebral vasospasm--an experimental study].
    Ishibashi Y; Konda R; Yoshimoto T; Suzuki J
    No Shinkei Geka; 1984 Feb; 12(2):133-9. PubMed ID: 6717739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenesis of cerebral vasospasm following subarachnoid hemorrhage].
    Sasaki T
    No To Shinkei; 1993 Sep; 45(9):799-808. PubMed ID: 8217406
    [No Abstract]   [Full Text] [Related]  

  • 20. [A random sample study of therapeutic effect of beta-receptor blocking agents in patients with subarachnoid hemorrhage].
    Wang ML
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):141-3, 187. PubMed ID: 1889320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.